How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
39
NTRA Quote, Financials, Valuation and Earnings
Last price:
$230.93
Seasonality move
:
5.42%
Day range:
$229.14 - $235.01
52-week range:
$125.38 - $256.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.76x
P/B ratio:
25.78x
Volume:
947.1K
Avg. volume:
1.1M
1-year change:
37.61%
Market cap:
$32.3B
Revenue:
$1.7B
EPS (TTM):
-$2.28
Analysts' Opinion
-
Consensus RatingNatera, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $257.20, Natera, Inc. has an estimated upside of 11.11% from its current price of $231.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $186.00 representing 19.65% downside risk from its current price of $231.48.
Fair Value
-
According to the consensus of 15 analysts, Natera, Inc. has 11.11% upside to fair value with a price target of $257.20 per share.
NTRA vs. S&P 500
-
Over the past 5 trading days, Natera, Inc. has underperformed the S&P 500 by -5.44% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Natera, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Natera, Inc. has grown year-over-year revenues for 34 quarters straight. In the most recent quarter Natera, Inc. reported revenues of $592.2M.
Earnings Growth
-
Natera, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Natera, Inc. reported earnings per share of -$0.64.
Enterprise value:
31.4B
EV / Invested capital:
--
Price / LTM sales:
14.76x
EV / EBIT:
--
EV / Revenue:
14.85x
PEG ratio (5yr expected):
-3.52x
EV / Free cash flow:
335.98x
Price / Operating cash flow:
333.82x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.3B
Return On Assets:
-18%
Net Income Margin (TTM):
-14.61%
Return On Equity:
-26.6%
Return On Invested Capital:
-21.88%
Operating Margin:
-16.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $988.7M | $1.5B | $2.1B | $439.8M | $592.2M | |
| Gross Profit | $422.8M | $883.4M | $1.3B | $271.7M | $384.4M | |
| Operating Income | -$503.5M | -$242.1M | -$351.9M | -$39.3M | -$97.6M | |
| EBITDA | -$467.6M | -$204.9M | -$314.7M | -$31.1M | -$87.3M | |
| Diluted EPS | -$4.51 | -$1.77 | -$2.28 | -$0.26 | -$0.64 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $829.6M | $1.3B | $1.3B | $1.4B | |
| Total Assets | $1.3B | $1B | $1.4B | $1.6B | $1.8B | |
| Current Liabilities | $199.7M | $267.3M | $289.9M | $301.4M | $442M | |
| Total Liabilities | $552.4M | $647.5M | $661.9M | $712.4M | $569.3M | |
| Total Equity | $759M | $361.6M | $784.7M | $878.5M | $1.3B | |
| Total Debt | $328.5M | $359.8M | $350.9M | $385.5M | $104.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$270M | $24.7M | $194.3M | $51.8M | $59.4M | |
| Cash From Investing | $165.8M | $173.4M | -$71.7M | $42.5M | -$19.9M | |
| Cash From Financing | $715.8M | $26.1M | $26M | $1.7M | $1.9M | |
| Free Cash Flow | -$311.5M | -$43.7M | $93.6M | $25M | $24.5M | |
NTRA
Sector
Market Cap
$32.3B
$24.3M
Price % of 52-Week High
90.3%
49.95%
Dividend Yield
0%
0%
Shareholder Yield
0.1%
-1.67%
1-Year Price Total Return
37.61%
-21.37%
Beta (5-Year)
1.620
0.484
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$238.91
200-day SMA
Buy
Level
$182.02
Bollinger Bands (100)
Buy
Level
179.12 - 236.76
Chaikin Money Flow
Sell
Level
-192K
20-day SMA
Sell
Level
$238.39
Relative Strength Index (RSI14)
Sell
Level
45.05
ADX Line
Sell
Level
7.14
Williams %R
Neutral
Level
-77.5544
50-day SMA
Sell
Level
$234.38
MACD (12, 26)
Buy
Level
18.47
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-947.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (24.8338)
Buy
CA Score
(Annual)
Level (-0.1104)
Buy
Beneish M-Score
(Annual)
Level (-2.7237)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.118)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Stock Forecast FAQ
In the current month, NTRA has received 13 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NTRA average analyst price target in the past 3 months is $257.20.
-
Where Will Natera, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Natera, Inc. share price will rise to $257.20 per share over the next 12 months.
-
What Do Analysts Say About Natera, Inc.?
Analysts are divided on their view about Natera, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Natera, Inc. is a Sell and believe this share price will drop from its current level to $186.00.
-
What Is Natera, Inc.'s Price Target?
The price target for Natera, Inc. over the next 1-year time period is forecast to be $257.20 according to 15 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is NTRA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Natera, Inc. is a Buy. 13 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTRA?
You can purchase shares of Natera, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Natera, Inc. shares.
-
What Is The Natera, Inc. Share Price Today?
Natera, Inc. was last trading at $230.93 per share. This represents the most recent stock quote for Natera, Inc.. Yesterday, Natera, Inc. closed at $231.48 per share.
-
How To Buy Natera, Inc. Stock Online?
In order to purchase Natera, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NTRA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NTRA
Sector
P/E ratio
--
23.45x
PEG ratio
-3.52x
-0.01x
P/B ratio
25.78x
1.80x
Price / LTM sales
14.76x
1.53x
Growth Metrics
NTRA
Sector
Revenue growth
34.66%
4.08%
Earnings growth
-150.04%
9.94%
Revenue (5-year growth)
41.2%
6.27%
Earnings forecast
-$0.53
-$0.19
Profitability
NTRA
Sector
Profitability FY 2024
$1B
$3M
Return on invested capital
-21.88%
-33.25%
Return on assets
-18%
-29.67%
Return on equity
-26.6%
-38.71%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
NTRA
Sector
Total cash
$1B
$25M
Short term investments
$22.7M
$25M
Total assets
$1.7B
$72.5M
Long term debt
$104.4M
$2.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 66x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
67
PFSI alert for Jan 30
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Buy
78
GDXU alert for Jan 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Buy
88
JNUG alert for Jan 30
Direxion Daily Junior Gold Miners Idx Bull 2X Shs [JNUG] is down 26.98% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
